Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

December 06, 2023 • 00:17:57
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments
COR2ED - Oncology Medical Conversation
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

Dec 06 2023 | 00:17:57

/

Show Notes

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité University of Medicine, Germany) discuss the different therapeutic options available in colorectal and gastric cancer.

In this third episode, the experts turn their focus to earlier stage disease and consider how lessons learnt in the treatment of metastatic disease can be applied in the neo adjuvant setting for colorectal cancer by discussing data from the FOXTROT and NICHE trials and the adjuvant setting for gastric cancer by discussing data from CheckMate 577. Finally, the experts consider new promising data on targeting KRAS compared to the MEK and the ERK inhibitors.

Other Episodes

Episode

December 06, 2023 • 00:27:14
Episode Cover

Sarcoma: Updated bone sarcoma guidelines - Clinical implications

In this SARCOMA CONNECT Guidelines Podcast, two SARCOMA CONNECT Experts, Prof. Robert Maki and Prof. Silvia Stacchiotti, discuss recent updates in the ESMO and...

Listen

Episode

December 06, 2023 • 00:22:48
Episode Cover

Prostate cancer: Which mCSPC patients benefit from early treatment intensification? Case-based discussion

Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU...

Listen

Episode

December 06, 2023 • 00:22:19
Episode Cover

Colorectal cancer: Flexible dosing of oral treatments in mCRC

In this podcast, Sven De Keersmaecker, RN and Assoc. Prof. Gerald Prager, MD discuss flexible dosing regimens of the oral treatments regorafenib, trifluridine /...

Listen